Literature DB >> 26859578

Five-year outpatient programme that provided children with continuous behavioural obesity treatment enjoyed high success rate.

Pernilla Danielsson1, Anna Bohlin2, Ana Bendito2, Annie Svensson2, Sven Klaesson2.   

Abstract

AIM: Results from long-time follow-up of obesity treatment in early childhood are lacking. We investigate long-term continuous behavioural childhood obesity treatment and factors of importance for treatment effect.
METHOD: A five-year longitudinal retrospective controlled study of children aged five to 13 years in obesity treatment, divided into three groups depending on age at start of treatment. Outcome is presented as change in degree of obesity, body mass index standard deviation score (BMI SDS), change in weight status and decrease of ≥0.5 BMI SDS units, in relation to a age-matched obese comparison group.
RESULTS: In total, 220 children (46% females) were included. After five years of treatment, the decrease in BMI SDS was significant in all age groups with the largest effect in age group 4-6 years. Compared to the comparison group (n = 369), the decline in BMI SDS was greater (p = 0.001). After five years of treatment, 48% of the patients were cured from their obesity and 72% reached a decline of 0.5 BMI SDS units. Age at start of treatment was the only factor affecting treatment efficacy.
CONCLUSION: The ability to reach a significant weight loss in a paediatric outpatient clinic is promising through a long-term behavioural obesity treatment. ©2016 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Behavioural treatment; Childhood obesity; Long-term treatment; Outpatient paediatric clinic

Mesh:

Year:  2016        PMID: 26859578     DOI: 10.1111/apa.13360

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  6 in total

1.  The Correlation Between Parental Perceptions and Readiness to Change with Participation in a Pediatric Obesity Program Serving a Predominantly Black Urban Community: A Retrospective Cohort Study.

Authors:  Sarita Dhuper; Nagla Bayoumi; Janhavi Dalvi; Barry Panzer
Journal:  Matern Child Health J       Date:  2020-11-25

2.  Predicting the development of overweight and obesity in children between 2.5 and 8 years of age: The prospective ABIS study.

Authors:  Karel Duchen; Mike Jones; Åshild Olsen Faresjö; Tomas Faresjö; Johnny Ludvigsson
Journal:  Obes Sci Pract       Date:  2020-03-25

3.  Effects of a multidisciplinary weight loss intervention in overweight and obese children and adolescents: 11 years of experience.

Authors:  Chiara Mameli; Jesse C Krakauer; Nir Y Krakauer; Alessandra Bosetti; Chiara Matilde Ferrari; Laura Schneider; Barbara Borsani; Sara Arrigoni; Erica Pendezza; Gian Vincenzo Zuccotti
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

4.  Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.

Authors:  Torsten Olbers; Andrew J Beamish; Eva Gronowitz; Carl-Erik Flodmark; Jovanna Dahlgren; Gustaf Bruze; Kerstin Ekbom; Peter Friberg; Gunnar Göthberg; Kajsa Järvholm; Jan Karlsson; Staffan Mårild; Martin Neovius; Markku Peltonen; Claude Marcus
Journal:  Lancet Diabetes Endocrinol       Date:  2017-01-06       Impact factor: 32.069

5.  Adapting pediatric obesity care to better suit adolescent patients: Design of a treatment platform and results compared with standard care in the national patient quality register.

Authors:  Annika Janson; Anna Bohlin; Britt-Marie Johansson; Sofia Trygg-Lycke; Fredrika Gauffin; Sven Klaesson
Journal:  Obes Sci Pract       Date:  2021-06-23

Review 6.  Characteristics of Multicomponent Interventions to Treat Childhood Overweight and Obesity in Extremely Cold Climates: A Systematic Review of a Randomized Controlled Trial.

Authors:  Javier Albornoz-Guerrero; Sonia García; Guillermo García Pérez de Sevilla; Igor Cigarroa; Rafael Zapata-Lamana
Journal:  Int J Environ Res Public Health       Date:  2021-03-17       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.